000			02138 a2200601 4500
005			20250518004733.0
264		0	_c20190528
008			201905s 0 0 eng d
022			_a1473-5687
024	7		_a10.1097/MEG.0000000000001299 _2doi
040			_aNLM _beng _cNLM
100	1		_aLv, Duo-Duo
245	0	0	_aA retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection. _h[electronic resource]
260			_bEuropean journal of gastroenterology & hepatology _c03 2019
300			_a382-388 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAntiviral Agents _xadverse effects
650	0	4	_aBenzimidazoles _xadverse effects
650	0	4	_aCarbamates _xadverse effects
650	0	4	_aDrug Combinations
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFluorenes _xadverse effects
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xdrug effects
650	0	4	_aHepatitis C, Chronic _xcomplications
650	0	4	_aHeterocyclic Compounds, 4 or More Rings _xadverse effects
650	0	4	_aHumans
650	0	4	_aImidazoles _xadverse effects
650	0	4	_aLiver Cirrhosis _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPyrrolidines
650	0	4	_aRNA, Viral _xblood
650	0	4	_aRetrospective Studies
650	0	4	_aSofosbuvir _xadverse effects
650	0	4	_aSustained Virologic Response
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUridine Monophosphate _xadverse effects
650	0	4	_aValine _xanalogs & derivatives
650	0	4	_aViral Load
650	0	4	_aViral Nonstructural Proteins _xantagonists & inhibitors
700	1		_aWang, Meng-Lan
700	1		_aChen, En-Qiang
700	1		_aWu, Dong-Bo
700	1		_aTao, Ya-Chao
700	1		_aZhang, Dong-Mei
700	1		_aTang, Hong
773	0		_tEuropean journal of gastroenterology & hepatology _gvol. 31 _gno. 3 _gp. 382-388
856	4	0	_uhttps://doi.org/10.1097/MEG.0000000000001299 _zAvailable from publisher's website
999			_c29000107 _d29000107